Clinical Trial Update: A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating APO866 for Cutaneous T-cell Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• APO866

Snippet

Sponsor: Valerio Therapeutics | Conditions: Cutaneous T-cell Lymphoma | Phase 2 | Status: COMPLETED